Clinical Trial: A Study of VV-14303 for the Treatment of Metabolic Dysfunction-associated Steatohepatitis (MASH)

U.S., July 29 -- ClinicalTrials.gov registry received information related to the study (NCT07732400) titled 'A Study of VV-14303 for the Treatment of Metabolic Dysfunction-associated Steatohepatitis (MASH)' on July 14.

Brief Summary: A Study of VV-14303 for the Treatment of Metabolic dysfunction-associated steatohepatitis (MASH)

Study Start Date: July, 2026

Study Type: INTERVENTIONAL

Condition: Metabolic Dysfunction-associated Steatohepatitis (MASH)

Intervention: GENETIC: VV-14303

will be administered via ultrasound guided intramuscular injections

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Kriya Therapeutics, Inc.

Published by HT Digital Content Services with permission from Health Daily Digest....